This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Cyclooxygenase 3D structures
From Proteopedia
(Difference between revisions)
(New page: == 3D Structures of cyclooxygenase == Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *COX I or prostaglandin H2 sy...) |
|||
| (One intermediate revision not shown.) | |||
| Line 6: | Line 6: | ||
*COX I or prostaglandin H2 synthase I or prostaglandin G/H synthase I | *COX I or prostaglandin H2 synthase I or prostaglandin G/H synthase I | ||
| + | **[[6y3c]] - hCOX I - human<br /> | ||
**[[3n8v]], [[1prh]] - sCOX I – sheep<br /> | **[[3n8v]], [[1prh]] - sCOX I – sheep<br /> | ||
**[[1pth]] – sCOX I + aspirin<br /> | **[[1pth]] – sCOX I + aspirin<br /> | ||
| Line 16: | Line 17: | ||
**[[3n8x]], [[3n8z]], [[1eqg]], [[5wbe]] - sCOX I + anti-inflammatory drug<br /> | **[[3n8x]], [[3n8z]], [[1eqg]], [[5wbe]] - sCOX I + anti-inflammatory drug<br /> | ||
**[[3n8y]] - sCOX I + aspirin + anti-inflammatory drug<br /> | **[[3n8y]] - sCOX I + aspirin + anti-inflammatory drug<br /> | ||
| - | **[[2oye]], [[2oyu]], [[1ebv]], [[1eqh]], [[1ht5]], [[1ht8]], [[1q4g]], [[5u6x]] - sCOX I + inhibitor<br /> | + | **[[2oye]], [[2oyu]], [[1ebv]], [[1eqh]], [[1ht5]], [[1ht8]], [[1q4g]], [[5u6x]], [[7jxt]] - sCOX I + inhibitor<br /> |
**[[1diy]], [[1fe2]] – sCOX I + arachidonic acid<br /> | **[[1diy]], [[1fe2]] – sCOX I + arachidonic acid<br /> | ||
*COX II or prostaglandin H2 synthase II or prostaglandin G/H synthase II | *COX II or prostaglandin H2 synthase II or prostaglandin G/H synthase II | ||
| - | **[[5f19]] - hCOX II | + | **[[5f19]] - hCOX II<br /> |
**[[5f1a]] – hCOX II (mutant) + salicylate<br /> | **[[5f1a]] – hCOX II (mutant) + salicylate<br /> | ||
**[[5ikq]], [[5ikr]], [[5ikt]], [[5ikv]], [[5kir]] - hCOX II + anti-inflammatory drug<br /> | **[[5ikq]], [[5ikr]], [[5ikt]], [[5ikv]], [[5kir]] - hCOX II + anti-inflammatory drug<br /> | ||
| Line 33: | Line 34: | ||
**[[3hs5]], [[3hs6]], [[3hs7]], [[3krk]], [[3mdl]], [[3olt]], [[3olu]], [[3qh0]] - mCOX II (mutant) + fatty acid substrate<br /> | **[[3hs5]], [[3hs6]], [[3hs7]], [[3krk]], [[3mdl]], [[3olt]], [[3olu]], [[3qh0]] - mCOX II (mutant) + fatty acid substrate<br /> | ||
**[[3ln0]], [[3mqe]], [[3ntg]] - mCOX II + benzopyran inhibitor<br /> | **[[3ln0]], [[3mqe]], [[3ntg]] - mCOX II + benzopyran inhibitor<br /> | ||
| + | **[[6v3r]] – mCOX II + harmaline analog<br /> | ||
**[[4rut]] – mCOX II + arachidonic acid<br /> | **[[4rut]] – mCOX II + arachidonic acid<br /> | ||
| + | **[[6ofy]] – mCOX II (mutant) + arachidonic acid<br /> | ||
**[[1cvu]] – mCOX II + peptide + arachidonic acid<br /> | **[[1cvu]] – mCOX II + peptide + arachidonic acid<br /> | ||
**[[1ddx]] – mCOX II + prostaglandin + arachidonic acid<br /> | **[[1ddx]] – mCOX II + prostaglandin + arachidonic acid<br /> | ||
Current revision
3D Structures of cyclooxygenase
Updated on 04-December-2022
